Navigation Links
Media invitation: Pioneer of organ-on-a-chip technology to speak at Imperial College London
Date:5/17/2011

The potential of microscopic organ-on-a-chip devices that mimic the way real organs work, so that scientists and engineers can model the effects of therapies more accurately, will be discussed by a pioneer in bioengineering at Imperial College London this week.

Professor Don Ingber, Director of the Wyss Institute for Biologically Inspired Engineering at Harvard University, will deliver the inaugural Bagrit Lecture, which will be held at Imperial on Thursday 19 May 2011, from 17.30 to 18.30. He will talk about advances by scientists and engineers who are using biology as the inspiration for the development of novel technologies for use in medicine, industry and the environment, and the challenges they face.

The lecture forms part of the College's celebration of 20 years of research, teaching and innovation in bioengineering at Imperial. The celebrations also provide an opportunity for the department to commemorate the ongoing support from the Sir Leon Bagrit Memorial Trust, which helped to establish bioengineering at the College.

Professor Ingber's most recent innovation is a complex, three-dimensional model of a breathing lung on a microchip that incorporates living human lung cells into computer chip technology. This device mimics how the lung works so that scientists can more accurately model the effects of environmental toxins on human lungs. Researchers can also use the device to monitor how the lungs absorb aerosolized pharmaceuticals and to assess the safety and effectiveness of new drugs.

In his lecture, Professor Ingber will talk about some of the advantages of using organ-on-a-chip technologies, which could accelerate the introduction of new drugs to market, provide an alternative to animal studies, and lower research costs.

Professor Ingber is also a pioneer in investigating the fundamental design principles that govern the way that molecules are structured into living cells and how these cells are integrated within tissues and organs during embryo formation, which is a process called "tensegrity". He will review his research into tensegrity and other findings that reveal how living cells and tissues change shape, move, grow, and self-heal. Understanding these underlying principles in more detail is enabling researchers to mimic biology so that they can develop technologies such as the organ-on-a-chip device.

Professor Ross Ethier, Head of the Department of Bioengineering at Imperial College London, says:

"Don Ingber's work represents the future of bioengineering. He is a pioneer who has helped us to understand how cells are designed. Now he is leading the way, using new microscopic fabrication techniques that incorporate human cells, to make devices to diagnose, understand and treat human disease. As we celebrate 20 years of bioengineering at the College, it is fitting to have such pioneer among us to discuss what the future holds in this exciting scientific field."

Professor Ingber has authored more than 300 publications and 50 patents and has received numerous distinctions including the Pritzer Award from the Biomedical Engineering Society, Lifetime Achievement Award from the Society of In Vitro Biology, the Rous-Whipple Award from the American Society for Investigative Pathology, the Department of Defence Breast Cancer Innovator Award, and election as a Fellow in the American Institute for Medical and Biological Engineering.


'/>"/>

Contact: Colin Smith
cd.smith@imperial.ac.uk
44-207-594-6712
Imperial College London
Source:Eurekalert

Related biology news :

1. New book on intermediary metabolism reveals intriguing complexity
2. Illinois professor chairs committee that recommends immediate calories, protein for TBI
3. EULAR 2011 media update
4. Integrating instructional multimedia in nursery management, production courses
5. Protecting ecosystems, pollution remediation goals of research at UH
6. Media alert: ACMG 2011 Clinical Genetics Meeting -- press registration is now open
7. Media advisory -- Partnering to Fight TB: The Role of a TB Vaccine PDP
8. Petrol stations pollute their immediate surroundings
9. SRNL demonstrating low-energy remediation with patented microbes
10. Oil spill symposium to convene scientists, media, policymakers and community leaders
11. Oceanic garbage patch not nearly as big as portrayed in media
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2016)... , Dec. 20, 2016  As part of its longstanding ... leading personal genetics company, recently released its latest children,s book, ... The book focuses on the topics of inheritance and variation ... Standards (NGSS) taught in elementary school classrooms in the US. ... series by illustrator Ariana Killoran , whose previous book ...
(Date:12/20/2016)... 2016 The rising popularity of mobility ... is stoking significant interest in keyless access systems. ... low energy (BLE), biometrics and near-field communication (NFC) ... of wireless technologies in the automotive industry. This ... access systems opens the market to specialist companies ...
(Date:12/19/2016)... , España y TORONTO , 19 de ... con Northern Biologics Inc. que permitirá el desarrollo acelerado de MSC-1, ... clínicos en varios tipos de tumor en 2017, con múltiples sitios ... ... su clase con objetivo en el factor inhibidor de leucemia (LIF), ...
Breaking Biology News(10 mins):
(Date:1/18/2017)... Malden, MA (PRWEB) , ... January 18, 2017 ... ... announced today that Dr. Dante Leven successfully implanted SpineFrontier’s A-CIFT™ Solofuse-P™. The operation ... Medical Center in Valley Stream, NY. The procedure was an anterior cervical discectomy ...
(Date:1/18/2017)... OF PRUSSIA, PA (PRWEB) , ... January 18, ... ... disrupt clinical operations again at the CHI SCOPE Summit for Clinical Ops Executives ... AstraZeneca in engaging panel discussions to examine vital clinical research issues such as ...
(Date:1/18/2017)... DIEGO , Jan. 18, 2017  HUYA Bioscience ... of China,s pharmaceutical innovations, announced ... of Sciences Innovation and Investment Company (referred to as ... commercializing biomedical innovations discovered by leading scientists at CAS ... world. HUYA is the first company to ...
(Date:1/17/2017)... West Point, IA (PRWEB) , ... January 17, ... ... approval from China for Balance™ GT soybeans. The new Balance™ GT Soybean Performance ... tolerance to glyphosate and isoxaflutole, the active ingredient in the new Balance® Bean ...
Breaking Biology Technology: